Are Investors Being Too Paranoid About Pfizer Stock?

Investing in a top healthcare company whose share price has been tanking in recent years could present a huge opportunity for investors, especially when that company has been bolstering its growth prospects via acquisitions and expansion of its pipeline. And if that stock trades at a cheap valuation and pays a high dividend, it would seem like a no-brainer buy today.If that were the case, however, shares of Pfizer (NYSE: PFE) would be taking off. Instead, investors are growing more apprehensive of the stock, not less; this already cheap stock is down a few percentage points this year.Are the concerns about the business valid, and could Pfizer be in trouble, or could this be a great opportunity to buy a potentially mispriced and undervalued healthcare stock?Continue readingWeiter zum vollständigen Artikel bei MotleyFool Weiter zum vollständigen Artikel bei MotleyFool